Sunnymeath Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$44K Sell
600
-16,550
-97% -$1.23M 0.06% 97
2016
Q3
$1.16M Buy
17,150
+4,390
+34% +$351K 2.54% 5
2016
Q2
$1.06M Buy
+12,760
New +$961K 1.54% 23

Other funds holding LLY

Sunnymeath Asset Management's LLY Position: Q4 2016 in Review

Sunnymeath Asset Management reduced its Eli Lilly (LLY) stake by 97% in Q4 2016, selling an estimated $1.23M and leaving 600 shares worth $44K. The position accounts for 0.06% of the portfolio, ranked #97.

Sunnymeath Asset Management first reported a position in LLY in Q2 2016 and has held it in 3 quarters since. The position peaked at $1.16M in Q3 2016. 1,212 funds tracked by Wall St. Rank hold LLY as of Q4 2016.

  • Sunnymeath Asset Management held 600 shares of Eli Lilly worth $44K as of Q4 2016.
  • Sunnymeath Asset Management sold 16,550 Eli Lilly shares in Q4 2016, an estimated $1.23M.
  • Eli Lilly made up 0.06% of Sunnymeath Asset Management's portfolio in Q4 2016, its #97 holding.
  • Sunnymeath Asset Management first reported a position in Eli Lilly in Q2 2016 and has held it in 3 quarters since.
  • Sunnymeath Asset Management's Eli Lilly position peaked at $1.16M in Q3 2016.
  • 1,212 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2016.

Based on Sunnymeath Asset Management's 13F filing for Q4 2016, filed 13 Jan 2017.